Humana Inc. (HUM) stock analysis

HUM · Humana Inc.

Latest recorded price: USD 461.25

Model-estimated fair value: USD 383.11. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Healthcare Plans

At $461.25, HUM trades 20.4% above the model's base-case value of $383.11. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $312.91 in the conservative case and $470.38 in the optimistic case, with a valuation confidence score of 45/100. About 90% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 11.8%, free cash flow margin 0.3%, ROIC 42.3%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare